An Open Phase I Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Single Dose and Repeat Dose Topical Administrations of Clascoterone Cream, 1% in Healthy Chinese Adult Subjects
Latest Information Update: 03 Feb 2025
At a glance
- Drugs Clascoterone (Primary)
- Indications Acne vulgaris
- Focus Pharmacokinetics
- Sponsors Zhejiang Sunshine Mandi Pharmaceutical
Most Recent Events
- 24 Jan 2025 Status changed from not yet recruiting to completed.
- 17 Jun 2024 New trial record